Viewing Study NCT00658892


Ignite Creation Date: 2025-12-24 @ 3:52 PM
Ignite Modification Date: 2026-02-07 @ 5:39 AM
Study NCT ID: NCT00658892
Status: COMPLETED
Last Update Posted: 2017-05-25
First Post: 2008-04-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
Sponsor: Mayo Clinic
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CDR0000593085
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View